Eric D. Nielson
Direct Line : 801.574.2636
215 South State Street Suite 1200
Salt Lake City, Utah 84111
Eric Nielson is an associate patent attorney at Fabian VanCott with a focus on patent preparation and prosecution. He worked as an R&D engineer in the medical device industry for over a decade with experience at large companies and startups. He was an inventor on numerous patents and eventually returned to school to become a patent attorney.
With experience in taking products from conception through commercialization to sustaining, Eric helps get inventions the protection they need without diverting or disrupting the team. He puts his background to work during prosecution to help USPTO Examiners understand practical benefits of the new invention. This practical approach to patents focuses on getting commercially relevant protection in a timely and efficient manner.
Eric represents large corporations, individual inventors, and startups before the USPTO and provides strategic insight on applications with the European and Chinese patent offices. With work experience in life sciences, software, chemistry, mechanical design, and materials, Eric understands what it takes to turn ideas into products and how to effectively protect those products.
He is licensed to practice in Utah, the U.S. Patent & Trademark Office, and is also admitted to the bar in Minnesota.
Admitted: U.S. Patent Office
Prepared patent applications for inventions in printers, mechanical devices, semiconductors, medical devices, and so on.
Provided opinions on potential infringement of medical devices and chemical formulations.
Appealed an examiner's rejection in several cases and drafted and filed briefs to support the appeals.
Prosecutes patent application through all stages of the process using the wide variety of programs available with the U.S. Patent Office.
J.D., Magna Cum Laude, University of Minnesota Law School, 2013
Book Awards in Evidence & Game Theory
Dean's List, 2L & 3L years
Minnesota Journal of Law, Science, & Technology, Staff Member, 2012 - 13
Note published in 14.2, "The Admission of Scientific Evidence in a Post-Crawford World"
Master of Medical Engineering, University of Washington, 2004
B.S., Chemical Engineering, Brigham Young University, 1997
Publications & Presentations
“Scientific Evidence in a Post-Crawford World,” 14 Minn. J. L. Sci. & Tech. 951 (2013)
FDA Lawyers Blog @Frommer, Lawrence & Haug LLP, coauthored,
Safety/Efficacy Data Masked and De-Identified in FDA Proposal, Jun 14, 2013
Compounding Pharmacies Further Regulated by FDA: Senate Bill Proposed, July 10, 2013
Physician Gift Provisions of the Affordable Care Act Kick In Today, Aug 1, 2013
New Medicine into Old Bottles, Quality and the U.S. Medical System, Mar 12, 2013
Pandemic Flu and You, Sept 19, 2012
Radiation delivery system utilizing intravascular ultrasound, U.S. 6,416,492
Device and method for percutaneous myocardial revascularization, U.S. 6,666,863
Method for cleaning and polishing metallic alloys and articles cleaned or polished thereby, U.S. 7,153,411
Diversion device to increase cerebral blood flow, U.S. 7,927,346
Medical articles that stimulate endothelial cell migration, U.S. 8,118,857
Medical devices and methods of making the same, U.S. 9,034,456
Internal medical devices containing peroxide-converting catalysts, US2007/0154466
Apparatus and methods for implanting objects, such as bronchoscopically implanting markers in the lung of patients, US2010/0036241
Methods and apparatus for external beam radiation treatments of resection cavities, US2010/0298858
Implantable devices and methods for external beam radiation treatments, US2011/0130655